Have a look at the US Meaningful Use 1 & 2 quality measure smoking
criteria... having said that, the smoking measures were/are so
convoluted they probably encouraged substance abuse among the poor souls
that had to figure out how to implement them.
Joseph
On 16-02-18 06:04 PM, Marcus Baw wrote:
Hi Heather,
I have a couple of years' experience dealing with and prescribing for
substance misuse in a British prison environment. The main drugs in
question were opioids, cocaine, amphetamines, benzodiazepines,
alcohol, and commonly abused prescription drugs such as pregabalin and
gabapentin.
I'm not sure if this stuff is helpful from a 'modelling' point of view
but I'm happy to help out if it's in any way useful.
M
On 18 February 2016 at 06:55, Rikard Lövström
<rikard.lovst...@gmail.com <mailto:rikard.lovst...@gmail.com>> wrote:
Hi Heather,
I did a Powerpoint presentation in 2011 looken at 30 key figures
from quality registers on tobacco use, compared it to the 10 put
forward by an expert group and finally concluded on the two (!) I
thought was sufficient.
I can try to find it. By the weekend.
Kind regards,
Rikard
Rikard Lövström
Den 18 feb 2016 07:50 skrev "Heather Leslie"
<heather.les...@oceaninformatics.com
<mailto:heather.les...@oceaninformatics.com>>:
Hi everyone,
The CKM Editorial teams in Norway and the international
openEHR CKM are seeking expertise for development of our
tobacco, drug and alcohol archetypes – all of which follow a
similar pattern around addition and its management.
The tobacco archetype in particular is causing some difficulty
in cracking the best pattern – the multitude of ways that this
data is represented in current systems is compounded by the
multitude of different forms of tobacco use (non-smoking and
smoking) and forms of tobacco used in smoking… There has been
a lot of discussion and various iterations over the past few
years – it is now time to try to pin it down and publish.
We think that consultation with an expert or two in this area
will help us establish the best approach for a robust
candidate archetype, which will then go out to the community
for further review and collaboration.
If you’d like to volunteer your services, please let me know.
If you can refer me to someone else who could assist, please
do so.
Many thanks in anticipation,
Heather
*Dr Heather Leslie *MBBS FRACGP FACHI
*Informatics Lead*, Ocean Informatics
<http://www.oceaninformatics.com/>
*Clinical Programme Lead, *openEHR Foundation
<http://www.openehr.org/>
p: +61 418 966 670 <tel:%2B61%20418%20966%20670> skype:
heatherleslie twitter: @omowizard
_______________________________________________
openEHR-clinical mailing list
openEHR-clinical@lists.openehr.org
<mailto:openEHR-clinical@lists.openehr.org>
http://lists.openehr.org/mailman/listinfo/openehr-clinical_lists.openehr.org
_______________________________________________
openEHR-clinical mailing list
openEHR-clinical@lists.openehr.org
<mailto:openEHR-clinical@lists.openehr.org>
http://lists.openehr.org/mailman/listinfo/openehr-clinical_lists.openehr.org
_______________________________________________
openEHR-clinical mailing list
openEHR-clinical@lists.openehr.org
http://lists.openehr.org/mailman/listinfo/openehr-clinical_lists.openehr.org
_______________________________________________
openEHR-clinical mailing list
openEHR-clinical@lists.openehr.org
http://lists.openehr.org/mailman/listinfo/openehr-clinical_lists.openehr.org
